Freeze Drying Equipment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the freeze drying equipment market size was valued at USD 2.49 billion in 2025 and is estimated to grow from USD 2.69 billion in 2026 to reach USD 3.99 billion by 2031, at a CAGR of 8.16% during the forecast period (2026-2031).

This report is Segmented by Product Type (Tray-Style, Bench Top, Industrial, and Laboratory Freeze Dryers), Scale of Operation (Laboratory, Pilot, and Industrial Scale), Application (Pharmaceuticals, Biotechnology, Food Processing, Nutraceuticals, and Others), and Geography (North America, Europe, Asia-Pacific, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Freeze Drying Equipment Market Trends and Insights

Rising Biologics, Vaccines, and Injectable Manufacturing

Pharmaceutical manufacturers are increasingly prioritizing spending on equipment for biologics, vaccines, and injectable therapies. These products, sensitive to heat, moisture, and storage conditions, underscore the importance of lyophilization in ensuring stability during sterile manufacturing. Consequently, as the output of injectables rises, so does the demand for pharmaceutical-grade systems in the freeze-drying equipment market. This is particularly true for facilities handling regulated products and export programs. Manufacturers face heightened pressure to ensure validated cycle reproducibility, contamination control, and support for intricate fill-finish workflows, all while maintaining product quality.

Sterility Assurance Pressure from Annex 1 and Aseptic Manufacturing

The updated European Union GMP Annex 1 has catalyzed a compliance-driven overhaul of older lyophilization systems. Effective August 2024, the binding lyophilization section heightened operational demands on manually loaded systems lacking advanced contamination controls, as highlighted by JUBILANT HOLLISTERSTIER. The framework advocates for isolators, restricted access barrier systems, and robust contamination control strategies, nudging buyers towards modern platforms over mere maintenance of legacy systems. Health Canada's alignment with Annex 1 amplifies this regulatory pressure, extending its reach beyond the EU and into another significant pharmaceutical market.

High Upfront Capital Cost Versus Conventional Drying

Capital costs remain a significant barrier for first-time buyers, particularly contract manufacturers comparing lyophilization with lower-cost drying technologies. Production-scale pharmaceutical systems involve high acquisition expenses, which increase further with the addition of CIP and SIP infrastructure, clean utilities, containment features, and barrier technologies. These costs extend payback periods and make them sensitive to financing conditions, customer visibility, and plant utilization assumptions. Smaller CDMOs in India and Southeast Asia prefer modular or scaled-down installations when entering the freeze-drying equipment market, avoiding large integrated lines. This creates distinct demand tiers between high-capex pharmaceutical installations and cautious buyers still gaining experience in freeze-drying operations.

Other drivers and restraints analyzed in the detailed report include:

1. Automation, IoT, and PAT Adoption in Lyophilization Systems
2. Expanding Freeze-Dried Food Demand Across Premium and Functional Segments
3. Energy Intensity and Utility Load Requirements

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, industrial freeze dryers captured 45.67% of the market, emphasizing their critical role in large-scale pharmaceutical and food operations that demand high throughput and consistent cycles. These systems are ideal for fixed product portfolios, aseptic lines, and facilities requiring Annex 1 compliance, driving demand for isolator-integrated setups. Tray-style freeze dryers, projected to grow at a 10.10% CAGR through 2031, are gaining popularity in multi-product sites and contract manufacturing environments due to their flexibility.

Rotary freeze dryers are preferred for bulk powder applications, utilizing continuous tumbling to improve morphology and accelerate drying compared to shelf-based methods. General-purpose systems are increasingly adopted in nutraceutical and specialty chemical processing, attracting first-time users who do not require fully validated pharmaceutical configurations. In May 2026, IMA Life launched the F57 EVO COMPACT freeze dryer, targeting manufacturers seeking production-grade performance in a compact design. GEA expanded the premium segment in February 2026 with its ALUS automatic loading and unloading systems, designed to minimize manual intervention and enhance contamination control in Annex 1-sensitive environments. These advancements indicate a market shift toward integrated solutions that combine loading, drying, and unloading.

Complete Report Scope:

• By Product Type
  • Tray-Style Freeze Dryers
  • Manifold Freeze Dryers
  • Rotary Freeze Dryers
  • Bench Top Freeze Dryers
  • Industrial Freeze Dryers
  • Laboratory Freeze Dryers
  • General Purpose Freeze Dryers
• By Scale of Operation
  • Laboratory Scale
  • Pilot Scale
  • Industrial Scale
• By Application
  • Pharmaceuticals
  • Biotechnology
  • Food Processing
  • Surgical Procedures
  • Nutraceuticals
  • Other Applications in Freeze Drying Equipment
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

In 2025, North America accounted for 39.25% of the global freeze-drying equipment market, driven by a strong pharmaceutical manufacturing base, an extensive CDMO network, and stringent regulatory oversight. The U.S. remains the primary demand center, with sterile manufacturing sites expanding capacity and replacing older systems with automated, compliant alternatives. Biologics development further sustains demand for validated pharmaceutical lyophilizers among innovators and contract producers. In January 2026, IMA Life partnered with Sharp Sterile Manufacturing on a USD 28 million expansion in Lee, Massachusetts, featuring a fully automated isolated filling line and a high-performance lyophilizer to double site filling capacity. In Canada, Annex 1-aligned guidance is driving replacement demand by raising expectations for contamination control and aseptic processing.

Europe combines regulatory-driven replacement demand with a strong OEM manufacturing base, maintaining its importance in the freeze-drying equipment market. Germany leads the region with large pharmaceutical manufacturing operations and key equipment suppliers. In February 2026, GEA opened its pharmaceutical freeze-drying technology center in Elsdorf, investing over EUR 80 million (approximately USD 85 million) to expand R&D, production, and service capabilities. In March 2026, LYOCONTRACT and Syntegon initiated a EUR 50 million (approximately USD 53 million) expansion of a freeze-drying facility in Ilsenburg, Germany, with a new vial line expected by summer 2027.

Asia-Pacific is projected to grow at an 11.20% CAGR through 2031, making it the fastest-growing regional market. China is increasing procurement at biologics facilities by aligning with international regulatory standards and building export-ready capacity. India is gaining traction with CDMO expansions, sterile dosage growth, and supportive policies driving demand for pharmaceutical-grade installations. Japan and South Korea contribute through advanced pharmaceutical and food processing sectors, emphasizing precision systems and process control. The Middle East, Africa, and South America, while smaller in demand, are strategically important as local vaccine manufacturing and reduced cold-chain dependency boost interest in domestic lyophilization capabilities.

1. Azbil
2. Biopharma Process Systems Ltd.
3. Buchi Labortechnik
4. Christ Freeze Dryers GmbH
5. Cuddon Freeze Dry
6. GEA Group
7. Harvest Right, LLC
8. HOF Sonderanlagenbau
9. IMA Group
10. Kyowa Vacuum Engineering Co., Ltd.
11. Labconco
12. Martin Christ Gefriertrocknungsanlagen
13. Millrock Technology, Inc.
14. Optima Packaging Group
15. SP Scientific LLC
16. SPX Technologies, Inc.
17. Thermo Fisher Scientific
18. Tofflon Science and Technology Group Co., Ltd.
19. Yamato Scientific Co., Ltd.
20. ZIRBUS technology

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support